EFFECTIVENESS OF OSAS THERAPIES (a.m.)
Presented by Dr. Olivier Vanderveken
This lecture will focus mainly on the non-CPAP options for the treatment of obstructive sleep apnea (OSA) with emphasis on oral appliance therapy using Mandibular Advancement Devices (MAD) and hypoglossal nerve stimulation (HNS) therapy.
At the end the audience should better understand:
- The role of pathophysiological endotyping in the « up-front » selection of candidates for MAD or HNS or other non-CPAP options such as upper airway surgery and positional therapy
- The limitations and barriers of each OSA therapy in terms of overall clinical effectiveness and reimbursement
- The indications and contraindications of each therapeutic option
- The importance of combination therapy in selected cases
DENTAL SLEEP MEDICINE FROM A TO ZZZ… (p.m.)
Presented by Dr. Fernanda Almeida
Obstructive Sleep Apnea (OSA) is a major health problem affecting over 10% of the adult population and is the cause of significant increases in healthcare costs, morbidity, and mortality. They can cause increased daytime sleepiness, fatigue, lead to crashes and injuries, predispose to cardiovascular disease, and lead to premature death in at-risk subjects.
There is also increasing evidence suggesting that mandibular advancement splints (MAS) are a first-line therapy for OSA.